墨西哥无医保慢性肾病患者死亡率分析:国家肾脏健康政策的契机
这项前瞻性队列研究纳入850例晚期慢性肾脏病患者,分析无医保患者的死亡率。结果显示,无医保患者3年死亡率为56.7%,显著高于有社保患者的38.2%(P<0.001);无医保使死亡风险增加(风险比2.64,95%CI 1.84-3.79;P=0.001)。结论呼吁墨西哥建立协调的国家肾脏健康与治疗计划。
要点
- 无医保的晚期CKD患者3年死亡率达56.7%,显著高于有社保者的38.2%。
- 无医保使死亡风险增加2.64倍(95%CI 1.84-3.79;P=0.001)。
- 墨西哥需建立国家肾脏健康与治疗计划以覆盖ESRD患者。
核心结论
- 无医保的晚期慢性肾脏病患者死亡率显著高于有社保者,墨西哥需建立国家肾脏健康与治疗计划。
研究设计与样本
- 前瞻性队列研究,纳入850例晚期慢性肾脏病患者,采用Cox比例风险模型分析死亡风险因素。
主要发现
- 患者平均年龄44.8±17.2岁,入院时87.6%无社保覆盖肾脏替代治疗费用,91.3%家庭月收入低于300美元。
- 研究3年内,28.8%的患者加入了墨西哥社保项目。
- 无医保患者3年死亡率为56.7%,有社保患者为38.2%(P<0.001)。
- 无医保使死亡风险增加(风险比2.64,95%CI 1.84-3.79;P=0.001)。
临床怎么用
- 临床应关注无医保晚期CKD患者的高死亡风险,推动医保覆盖和早期干预。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Despite a systematic increase in the coverage of patients with end-stage renal disease (ESRD) who have received dialytic therapies and transplantation over the past 2 decades, the Mexican health system currently still does not have a program to provide full coverage of ESRD. Our aim was to analyze mortality in patients with ESRD without health insurance. METHODS: This was a prospective cohort study of 850 patients with advanced chronic kidney disease (CKD). Risk factors associated with death were calculated using a Cox's proportional hazards model. We used the statistical package SPSS version 22.0 for data analysis. RESULTS: The mean age of patients was 44.8 ± 17.2 years old. At the time of hospital admission, 87.6% of the population did not have a social security program to cover the cost of renal replacement treatment, and 91.3% of families had an income below US$300 per month. During the 3 years of the study, 28.8% of the cohort patients were enrolled in 1 of Mexico's social security programs. The 3-year mortality rate was of 56.7% among patients without access to health insurance, in contrast to 38.2% of patients who had access to a social security program that provided access to renal replacement therapy (P < 0.001). Risk factor analysis revealed that not having health insurance increased mortality (risk ratio: 2.64, 95% confidence intervals: 1.84-3.79; P = 0.001). CONCLUSION: Mexico needs a coordinated National Kidney Health and Treatment Program. A program of this nature should provide the basis for an appropriate educational and intervention strategy for early detection, prevention, and treatment of patients with advanced chronic kidney disease.
引用
- Valdez-Ortiz R, Navarro-Reynoso F, Olvera-Soto MG, et al. Mortality in Patients With Chronic Renal Disease Without Health Insurance in Mexico: Opportunities for a National Renal Health Policy. Kidney Int Rep. 2018. PMID: 30197984. doi:10.1016/j.ekir.2018.06.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。